Kiromic BioPharma, Inc.
KRBP · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $25,667 | $43,355 | $90,365 | $117,409 |
| - Cash | $1,137 | $2,924 | $4,179 | $3,676 |
| + Debt | $14,568 | $14,714 | $13,369 | $13,581 |
| Enterprise Value | $39,098 | $55,145 | $99,555 | $127,314 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$557 | -$557 |
| % Margin | – | – | – | – |
| EBITDA | -$5,157 | -$5,948 | -$5,311 | -$4,520 |
| % Margin | – | – | – | – |
| Net Income | -$6,491 | -$7,435 | -$6,911 | -$6,148 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.31 | -0.31 | -4.59 | -4.71 |
| % Growth | 0% | 93.2% | 2.5% | – |
| Operating Cash Flow | -$3,648 | -$1,931 | -$8,180 | -$5,699 |
| Capital Expenditures | -$28 | -$219 | -$98 | -$21 |
| Free Cash Flow | -$3,676 | -$2,150 | -$8,278 | -$5,720 |